Who we are

We are a Spanish pharmaceutical company focused on research and development of novel therapeutic and immunotherapeutic products with the purpose of introducing new compounds that addresses health disorders linked to dysfunction of TGF-beta signaling.

What we do

We investigate on new compounds that show promising approaches for treatment of severe diseases such as cancer and fibrosis.

read more
pharmaceutic

Innovative small molecules

Our goal is develop therapeutic products that modulates our own immune system.

Organ selective compounds

Targeting organ selectivity

Well validated targets

TGF-beta signaling as therapeutic target is our main focus

Our mission

The discovery and development of next generation therapeutic products for treatment of severe diseases
linked to TGF-beta.

Our vision

Improve life quality and ultimately cure people suffering from devastating conditions such as cancer.